SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-057627
Filing Date
2017-02-27
Accepted
2017-02-27 07:51:55
Documents
3
Period of Report
2017-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d336136d8k.htm 8-K 16442
2 EX-99.1 d336136dex991.htm EX-99.1 16584
3 GRAPHIC g336136g0225041710853.jpg GRAPHIC 2816
  Complete submission text file 0001193125-17-057627.txt   38304
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 17639625
SIC: 8731 Services-Commercial Physical & Biological Research